EyeCon 2024: Insights on transforming ocular surface disease management

Commentary
Video

Peter J. McDonnell, MD, and Laura M. Periman, MD, discussed innovations in treating ocular surface conditions, emphasizing patient-centered care and interdisciplinary collaboration.

Peter J. McDonnell, MD, and Laura M. Periman, MD, highlighted advancements in ocular surface disease and its treatment in a discussion at EyeCon 2024, held September 27 and 28, in Fort Lauderdale, Florida,

McDonnell, chief medical editor of sister brand Ophthalmology Times and cochair of EyeCon 2024, emphasized the challenges that clinicians face in integrating new information and technologies into their practices. Periman, who leads the Periman Eye Institute, shared her insights on transforming dry eye management into a specialized practice model, advocating for patient-centered care that prioritizes time and attention over rushed appointments.

They noted that conditions like cataract and refractive surgeries often exacerbate dry eye symptoms, underscoring the need for all practitioners to recognize and address ocular surface disease in their patients. The conversation highlighted that successful patient care relies on effective communication and knowledge sharing across different areas of expertise, particularly at educational platforms like EyeCon, where subspecialists gather to enhance their skills and understanding.

With ongoing challenges such as the increasing prevalence of myopia and age-related macular degeneration, the need for innovative care models is paramount. McDonnell and Periman encouraged attendees to leverage new strategies and insights from the conference to better serve their patients, ensuring that even those focusing on surgical interventions do not overlook the importance of ocular surface health. The dialogue underscored the collective commitment to advancing eye care and improving patient outcomes through continued education and collaboration.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
© 2025 MJH Life Sciences

All rights reserved.